Dibromodulcitol
- 30 September 1979
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 6 (3) , 191-204
- https://doi.org/10.1016/s0305-7372(79)80070-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The effect of dibromo-dulcitol, diepoxy-dulcitol and various new cytostatic hexitol derivatives on the metabolic activities of nucleic acids and proteins—IIBiochemical Pharmacology, 1976
- The effect of cytostatic hexitol derivatives on haematopoietic stem cells, the L1210 leukaemia and C22LR osteosarcomaPublished by Elsevier ,1975
- The absorption and metabolism of dibromodulcitol in patients with advanced cancerClinical Pharmacology & Therapeutics, 1972
- The role of the carrying molecule in the cross-resistance against sugar alcohol derivativesEuropean Journal of Cancer (1965), 1969
- Toxicity, hæmatological effects and anti-tumour activity of epoxides derived from disubstituted hexitols. Mode of action of mannitol myleran and dibromomannitolEuropean Journal of Cancer (1965), 1968
- Studies on cross-resistance to degranol- and dibromodulcitol-resistant yoshida tumoursInternational Journal of Cancer, 1968
- Observations on tumour cells in the circulating blood before and after chemotherapyEuropean Journal of Cancer (1965), 1968
- The effect of mannitol-myleran and two new dibromo-hexitols on the metabolic activities of nucleic acids and proteins—I.Biochemical Pharmacology, 1967
- Cross-resistance studies on 1,6-dibromo-dideoxy-D-mannitol(DBM)-resistant Yoshida S.C. sarcoma.British Journal of Cancer, 1967
- Kreuzresistenzuntersuchungen an, degranolresistenten NK/ly-Ascites-TumorenZeitschrift für Krebsforschung und Klinische Onkologie, 1966